The relationship between 5-hydroxyindoles and catecholamines.
D001812:Blood-Brain Barrier; D001923:Brain Chemistry; D001927:Brain Diseases / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism*; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000378:metabolism*; D008875:Middle Aged; D009069:Movement Disorders / Q000378:metabolism; D010649:Phenylalanine / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism; D014364:Tryptophan / Q000378:metabolism; D014556:Urine
D002395:Catecholamines; D012701:Serotonin; D010649:Phenylalanine; D006897:Hydroxyindoleacetic Acid; D014364:Tryptophan; D004298:Dopamine